Difference between revisions of "Team:UCC Ireland"

 
(20 intermediate revisions by 2 users not shown)
Line 12: Line 12:
 
     <!-- Bootstrap core CSS -->
 
     <!-- Bootstrap core CSS -->
 
     <link rel="stylesheet" href="https://2016.igem.org/Template:Team:UCC_Ireland/CSS?action=raw&amp;ctype=text/css">
 
     <link rel="stylesheet" href="https://2016.igem.org/Template:Team:UCC_Ireland/CSS?action=raw&amp;ctype=text/css">
 +
 +
    <script src="https://2016.igem.org/Template:Team:UCC_Ireland/JS?action=raw&amp;ctype=text/javascript"></script>
 
      
 
      
 
   </head>
 
   </head>
Line 26: Line 28:
 
               <span class="icon-bar"></span>
 
               <span class="icon-bar"></span>
 
             </button>
 
             </button>
−
               <a class="navbar-brand" href="#"><img style="height: 80px;" src="img/LIMITLESSLACTIS-WHITE.png" alt=""></a>
+
               <a class="navbar-brand" href="https://2016.igem.org/Team:UCC_Ireland"><img style="height: 80px;" src="https://static.igem.org/mediawiki/2016/a/a3/LIMITLESSLACTIS-WHITE.png" alt=""></a>
 
           </div>
 
           </div>
 
           <div id="navbar" class="navbar-collapse collapse">
 
           <div id="navbar" class="navbar-collapse collapse">
 
             <ul class="nav navbar-nav">
 
             <ul class="nav navbar-nav">
−
               <li class="active"><a href="#">Home</a></li>
+
               <li class="active"><a href="https://2016.igem.org/Team:UCC_Ireland">Home</a></li>
−
               <li><a href="project.html">Project</a></li>
+
               <li class="dropdown">
 +
                <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project<span class="caret"></span></a>
 +
                <ul class="dropdown-menu">
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Limitless_Lactis">Limitless Lactis</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/iRFP">iRFP In-Vitro Reporter</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Leishmaniasis">Leishmaniasis</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Proof">Proof</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Demonstrate">Demonstrate</a></li>
 +
                </ul>
 +
              </li>
 
               <li class="dropdown">
 
               <li class="dropdown">
 
                 <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Outreach<span class="caret"></span></a>
 
                 <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Outreach<span class="caret"></span></a>
 
                 <ul class="dropdown-menu">
 
                 <ul class="dropdown-menu">
−
                   <li><a href="silver.html">HP Silver</a></li>
+
                   <li><a href="https://2016.igem.org/Team:UCC_Ireland/HP/Silver">HP Silver</a></li>
−
                   <li><a href="gold.html">HP Gold</a></li>
+
                   <li><a href="https://2016.igem.org/Team:UCC_Ireland/HP/Gold">HP Gold</a></li>
 
                   <li role="separator" class="divider"></li>
 
                   <li role="separator" class="divider"></li>
−
                   <li><a href="application-scenario.html">Engagement</a></li>
+
                   <li><a href="https://2016.igem.org/Team:UCC_Ireland/Engagement">Engagement</a></li>
−
                   <li><a href="techno-moral-scenario.html">Integrated Practices</a></li>
+
                   <li><a href="https://2016.igem.org/Team:UCC_Ireland/Integrated_Practices">Integrated Practices</a></li>
 
                 </ul>
 
                 </ul>
 
               </li>
 
               </li>
−
               <li><a href="team.html">Team</a></li>
+
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Team">Team</a></li>
−
               <li><a href="notebook.html">Notes</a></li>
+
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Notebook">Notes</a></li>
−
               <li><a href="parts.html">Parts</a></li>
+
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Parts">Parts</a></li>
 
               <li class="dropdown">
 
               <li class="dropdown">
−
                 <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Collaborations <span class="caret"></span></a>
+
                 <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Collaborations<span class="caret"></span></a>
 
                 <ul class="dropdown-menu">
 
                 <ul class="dropdown-menu">
−
                   <li><a href="collaborations.html">iGEM Teams</a></li>
+
                   <li><a href="https://2016.igem.org/Team:UCC_Ireland/Collaborations">iGEM Teams</a></li>
 
                   <li role="separator" class="divider"></li>
 
                   <li role="separator" class="divider"></li>
 
                   <li class="dropdown-header">Synenergene</li>
 
                   <li class="dropdown-header">Synenergene</li>
−
                   <li><a href="application-scenario.html">Application Scenario</a></li>
+
                   <li><a href="https://2016.igem.org/Team:UCC_Ireland/Application_Scenario">Application Scenario</a></li>
−
                   <li><a href="techno-moral-scenario.html">Techno-Moral Scenario</a></li>
+
                   <li><a href="https://2016.igem.org/Team:UCC_Ireland/Techno_Moral_Newsletter">Techno-Moral Newsletter</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Blog.html">Techno-Moral Blog</a></li>
 
                 </ul>
 
                 </ul>
 
               </li>
 
               </li>
−
               <li><a href="interlab_study.html">Interlab</a></li>
+
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Interlab_Study">Interlab</a></li>
−
               <li><a href="achievements.html">Achievements</a></li>
+
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Achievements">Achievements</a></li>
−
               <li><a href="attributions.html">Attributions</a></li>
+
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Attributions">Attributions</a></li>
 
             </ul>
 
             </ul>
 
           </div>
 
           </div>
Line 67: Line 79:
 
           <div class="col-xs-12 col-md-12">
 
           <div class="col-xs-12 col-md-12">
  
 +
            <img style="width: 400px; display:block; margin:auto;" src="https://static.igem.org/mediawiki/2016/6/6b/T--UCC_Ireland--LIMITLESSLACTIS-BLACK.png" alt="">
 
              
 
              
−
            <img class="img-circle" style="width: 350px; display:block; margin:auto;" src="img/LIMITLESSLACTIS-BLACK.png" alt="">
 
−
            <p class="lead text-center" style="padding: 10px;">
 
−
              <a class="btn btn-primary btn-lg" href="#" role="button">Learn more</a>
 
−
            </p>
 
 
           </div>
 
           </div>
 
         </div><!-- /landing -->
 
         </div><!-- /landing -->
−
         <div class="col-md-12 social-badge">
+
          
−
          <a href="#abstract">
+
−
          <span class="fa fa-arrow-circle-down fa-5x"></span></a>
+
−
        </div>
+
  
 
         <div class="row text-center" id="abstract">
 
         <div class="row text-center" id="abstract">
Line 84: Line 90:
 
     <hr>
 
     <hr>
 
               <p class="lead text-left">
 
               <p class="lead text-left">
−
               <em>Lactococcus lactis</em>, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic L. lactis-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, Lutzomyia longipalpis. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.
+
               <em>Lactococcus lactis</em>, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic <em>L. lactis</em>-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, <em>Lutzomyia longipalpis</em>. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.
 
             </p>
 
             </p>
 
               <hr>
 
               <hr>
−
               <div class="embed-responsive embed-responsive-16by9">
+
               <div align="center" class="embed-responsive embed-responsive-16by9">
−
                  <iframe class="embed-responsive-item" src="https://www.youtube.com/embed/Dga9zislKtI"></iframe>
+
                <video controls class="embed-responsive-item">
 +
                  <source src="https://static.igem.org/mediawiki/2016/e/e3/T--UCC_Ireland--I-Like-It-Lactis-UCC-iGEM-2016-SONG.mp4" type="video/mp4">
 +
                </video>
 
               </div>
 
               </div>
 
           </div>
 
           </div>
Line 99: Line 107:
  
 
         <div class="row" id="sponsors">
 
         <div class="row" id="sponsors">
−
           <div class="col-xs-12 col-md-12 text-center text-uppercase">
+
           <div class="col-xs-12 col-md-11 col-md-11 text-center text-uppercase">
 
             <div class="row">
 
             <div class="row">
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/ccrc.png" alt="">
+
    <a href="http://apc.ucc.ie/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/f/f3/T--UCC_Ireland--apc.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/COMH.jpg" alt="">
+
    <a href="http://www.ccrc.ie/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/a/a6/T--UCC_Ireland--ccrc.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/Fyffes_SVG_logo.svg.png" alt="">
+
    <a href="https://www.ucc.ie/en/med-health/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/2/20/T--UCC_Ireland--COMH.jpg" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/genscripteditkevin.png" alt="">
+
    <a href="http://www.fyffes.us/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/f/f8/T--UCC_Ireland--Fyffes_SVG_logo.svg.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/IDT_logo_trans.png" alt="">
+
    <a href="http://www.genscript.com/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/5/5b/T--UCC_Ireland--genscripteditkevin.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/logo (1).png" alt="">
+
    <a href="http://www.lilly.ie/en/index.aspx" target="_blank"><img src="https://static.igem.org/mediawiki/2016/7/73/T--UCC_Ireland--hutchinsonlilly-2vd3ujlywuaxuzb5zmonpc.jpg" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/schoolofbiochemlogoeditkevin.png" alt="">
+
    <a href="http://eu.idtdna.com/site" target="_blank"><img src="https://static.igem.org/mediawiki/2016/b/b0/T--UCC_Ireland--IDT_logo_trans.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/apc.png" alt="">
+
    <a href="http://www.janssen.com/ireland/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/6/65/T--UCC_Ireland--Janssen.jpg" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/genscripteditkevin.png" alt="">
+
    <a href="https://www.synenergene.eu/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/e/ef/T--UCC_Ireland--logo%281%29.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/IDT_logo_trans.png" alt="">
+
    <a href="https://www.ucc.ie/en/biochemistry/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/0/03/T--UCC_Ireland--schoolofbiochemlogoeditkevin.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/sponsors/logo (1).png" alt="">
+
    <a href="http://www.ucc.ie/en/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/4/47/T--UCC_Ireland--ucc.png" alt=""></a>
−
              </div>
+
  </div>
−
             </div>
+
</div>
 +
             <br>
 +
            <br>
 +
            <br>
 +
            <br>
 +
          </div>
 +
        </div><!-- /sponsors -->
 
             <br>
 
             <br>
 
             <br>
 
             <br>
Line 147: Line 161:
 
     </div> <!-- /container full -->
 
     </div> <!-- /container full -->
  
−
 
−
 
−
    <!-- Bootstrap core JavaScript
 
−
    ================================================== -->
 
−
    <!-- Placed at the end of the document so the pages load faster -->
 
−
    <script src="https://2016.igem.org/Template:Team:UCC_Ireland/JS?action=raw&amp;ctype=text/javascript"></script>
 
 
   </body>
 
   </body>
 
</html>
 
</html>

Latest revision as of 00:07, 20 October 2016


UCC iGEM

Limitless Lactis: Intelligent Lactococcus lactis strains as a protein delivery platform for disease treatment.

Lactococcus lactis, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic L. lactis-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, Lutzomyia longipalpis. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.